BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19766583)

  • 1. Studies in serum support rapid formation of disulfide bond between unpaired cysteine residues in the VH domain of an immunoglobulin G1 molecule.
    Ouellette D; Alessandri L; Chin A; Grinnell C; Tarcsa E; Radziejewski C; Correia I
    Anal Biochem; 2010 Feb; 397(1):37-47. PubMed ID: 19766583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of variable regions of monoclonal antibodies by top-down mass spectrometry.
    Zhang Z; Shah B
    Anal Chem; 2007 Aug; 79(15):5723-9. PubMed ID: 17591752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding.
    Proba K; Honegger A; Plückthun A
    J Mol Biol; 1997 Jan; 265(2):161-72. PubMed ID: 9020980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-translational modification of nascent immunoglobulin heavy and light chains.
    Bergman LW; Kuehl WM
    J Supramol Struct; 1979; 11(1):9-24. PubMed ID: 118307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature of antibody heavy chain residue H6 strongly influences the stability of a VH domain lacking the disulfide bridge.
    Langedijk AC; Honegger A; Maat J; Planta RJ; van Schaik RC; Plückthun A
    J Mol Biol; 1998; 283(1):95-110. PubMed ID: 9761676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folding and oxidation of the antibody domain C(H)3.
    Thies MJ; Talamo F; Mayer M; Bell S; Ruoppolo M; Marino G; Buchner J
    J Mol Biol; 2002 Jun; 319(5):1267-77. PubMed ID: 12079363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interchain disulfide bonding in human IgG2 antibodies probed by site-directed mutagenesis.
    Allen MJ; Guo A; Martinez T; Han M; Flynn GC; Wypych J; Liu YD; Shen WD; Dillon TM; Vezina C; Balland A
    Biochemistry; 2009 May; 48(17):3755-66. PubMed ID: 19254029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel modification to monoclonal antibodies: thioether cross-link of heavy and light chains.
    Tous GI; Wei Z; Feng J; Bilbulian S; Bowen S; Smith J; Strouse R; McGeehan P; Casas-Finet J; Schenerman MA
    Anal Chem; 2005 May; 77(9):2675-82. PubMed ID: 15859580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of buried unpaired cysteines in a recombinant monoclonal IgG1 antibody.
    Zhang T; Zhang J; Hewitt D; Tran B; Gao X; Qiu ZJ; Tejada M; Gazzano-Santoro H; Kao YH
    Anal Chem; 2012 Aug; 84(16):7112-23. PubMed ID: 22794164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of trisulfide modification in antibodies.
    Gu S; Wen D; Weinreb PH; Sun Y; Zhang L; Foley SF; Kshirsagar R; Evans D; Mi S; Meier W; Pepinsky RB
    Anal Biochem; 2010 May; 400(1):89-98. PubMed ID: 20085742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and localization of unpaired cysteine residues in monoclonal antibodies by fluorescence labeling and mass spectrometry.
    Chumsae C; Gaza-Bulseco G; Liu H
    Anal Chem; 2009 Aug; 81(15):6449-57. PubMed ID: 19572546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for trisulfide bonds in a recombinant variant of a human IgG2 monoclonal antibody.
    Pristatsky P; Cohen SL; Krantz D; Acevedo J; Ionescu R; Vlasak J
    Anal Chem; 2009 Aug; 81(15):6148-55. PubMed ID: 19591437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of Fab-hinge disulfide connectivity in structural isoforms of a recombinant human immunoglobulin G2 antibody.
    Zhang B; Harder AG; Connelly HM; Maheu LL; Cockrill SL
    Anal Chem; 2010 Feb; 82(3):1090-9. PubMed ID: 20039682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains.
    Saerens D; Conrath K; Govaert J; Muyldermans S
    J Mol Biol; 2008 Mar; 377(2):478-88. PubMed ID: 18262543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
    Röthlisberger D; Honegger A; Plückthun A
    J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative stabilities of IgG1 and IgG4 Fab domains: influence of the light-heavy interchain disulfide bond architecture.
    Heads JT; Adams R; D'Hooghe LE; Page MJ; Humphreys DP; Popplewell AG; Lawson AD; Henry AJ
    Protein Sci; 2012 Sep; 21(9):1315-22. PubMed ID: 22761163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flexibility of human IgG subclasses.
    Roux KH; Strelets L; Michaelsen TE
    J Immunol; 1997 Oct; 159(7):3372-82. PubMed ID: 9317136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody.
    Liu H; Bulseco GG; Sun J
    Immunol Lett; 2006 Aug; 106(2):144-53. PubMed ID: 16831470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cysteinylation of a free cysteine in the Fab region of a recombinant monoclonal IgG1 antibody using Lys-C limited proteolysis coupled with LC/MS analysis.
    Gadgil HS; Bondarenko PV; Pipes GD; Dillon TM; Banks D; Abel J; Kleemann GR; Treuheit MJ
    Anal Biochem; 2006 Aug; 355(2):165-74. PubMed ID: 16828048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A; Plückthun A
    Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.